Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Walmart
WMT
|
$1.12B |
| 2 |
Microsoft
MSFT
|
$700M |
| 3 |
Walt Disney
DIS
|
$589M |
| 4 |
Linde
LIN
|
$549M |
| 5 |
Apple
AAPL
|
$486M |
Top Sells
| 1 |
Yum China
YUMC
|
$518M |
| 2 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
$480M |
| 3 |
Synopsys
SNPS
|
$424M |
| 4 |
Workday
WDAY
|
$406M |
| 5 |
Meta Platforms (Facebook)
META
|
$364M |
Sector Composition
| 1 | Technology | 23.57% |
| 2 | Financials | 12.22% |
| 3 | Industrials | 11.88% |
| 4 | Healthcare | 11.02% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KG
3626
Kestrel Group, Ltd.
KG
$203M
| $93.9K | ﹤0.01% |
41,729
-1,544
| -4% | -$3.47K |
|
3627
KORU Medical Systems
KRMD
$190M
| $93.8K | ﹤0.01% |
39,743
+24,225
| +156% | +$57.2K |
|
3628
FibroGen
FGEN
$48.2M
| $93.5K | ﹤0.01% |
39,804
-15,599
| -28% | -$36.7K |
|
3629
Acacia Research
ACTG
$322M
| $93.1K | ﹤0.01% |
17,463
-117,483
| -87% | -$626K |
|
3630
Zevra Therapeutics
ZVRA
$510M
| $92.3K | ﹤0.01% |
15,919
-585
| -4% | -$3.39K |
|
3631
Carisma Therapeutics
CARM
$19.5M
| $91.7K | ﹤0.01% |
40,409
+27,677
| +217% | +$62.8K |
|
3632
System1
SST
$55.5M
| $91.6K | ﹤0.01% |
46,744
+34,905
| +295% | +$68.4K |
|
|
AGEN
3633
Agenus
AGEN
$133M
| $91.6K | ﹤0.01% |
157,859
+6,677
| +4% | +$3.87K |
|
|
OCEA
3634
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $90.4K | ﹤0.01% |
+23,874
| New | +$90.4K |
|
3635
Actinium Pharmaceuticals
ATNM
$54M
| $90.2K | ﹤0.01% |
11,526
-35
| -0.3% | -$274 |
|
3636
Ovid Therapeutics
OVID
$86M
| $90.1K | ﹤0.01% |
29,554
-331
| -1% | -$1.01K |
|
3637
Larimar Therapeutics
LRMR
$323M
| $89.7K | ﹤0.01% |
11,816
-442
| -4% | -$3.36K |
|
|
AEF
3638
abrdn Emerging Markets Equity Income Fund
AEF
$246M
| $87.8K | ﹤0.01% |
17,391
-12,941
| -43% | -$65.4K |
|
3639
American Express Global Business Travel
GBTG
$3.88B
| $85.3K | ﹤0.01% |
14,197
-81
| -0.6% | -$487 |
|
3640
Lineage Cell Therapeutics
LCTX
$265M
| $84K | ﹤0.01% |
56,749
-130
| -0.2% | -$192 |
|
3641
Compass Therapeutics
CMPX
$473M
| $82.7K | ﹤0.01% |
41,763
-1,427
| -3% | -$2.83K |
|
3642
Atomera
ATOM
$101M
| $81.8K | ﹤0.01% |
13,287
+1,969
| +17% | +$12.1K |
|
3643
Quantum-Si Incorporated
QSI
$219M
| $78.9K | ﹤0.01% |
40,074
-147,860
| -79% | -$291K |
|
3644
Urban One Class A
UONE
$71.2M
| $75.9K | ﹤0.01% |
28,107
-6,681
| -19% | -$18K |
|
3645
United Homes Group
UHG
$247M
| $75.1K | ﹤0.01% |
+10,748
| New | +$75.1K |
|
3646
INNOVATE Corp
VATE
$74.1M
| $74.4K | ﹤0.01% |
106,126
-115,419
| -52% | -$80.9K |
|
3647
Prime Medicine
PRME
$558M
| $74.3K | ﹤0.01% |
+10,611
| New | +$74.3K |
|
3648
Waldencast
WALD
$186M
| $74.1K | ﹤0.01% |
11,403
-1,752
| -13% | -$11.4K |
|
3649
MarketWise
MKTW
$49.9M
| $73.9K | ﹤0.01% |
42,734
-5,508
| -11% | -$9.53K |
|
3650
BlackSky Technology
BKSY
$601M
| $73.9K | ﹤0.01% |
54,331
-2,009
| -4% | -$2.73K |
|